Coherus BioSciences, Inc. Annual Operating Income (Loss) in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Coherus BioSciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2012 to 2023.
  • Coherus BioSciences, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$6.39M, a 80% increase year-over-year.
  • Coherus BioSciences, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$138M, a 25.5% increase year-over-year.
  • Coherus BioSciences, Inc. annual Operating Income (Loss) for 2023 was -$203M, a 20.9% increase from 2022.
  • Coherus BioSciences, Inc. annual Operating Income (Loss) for 2022 was -$257M, a 2.65% increase from 2021.
  • Coherus BioSciences, Inc. annual Operating Income (Loss) for 2021 was -$264M, a 269% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$203M +$53.7M +20.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-15
2022 -$257M +$6.98M +2.65% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-15
2021 -$264M -$420M -269% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-15
2020 $156M +$48.6M +45.1% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-06
2019 $108M +$312M Jan 1, 2019 Dec 31, 2019 10-K 2022-02-23
2018 -$204M +$27.7M +11.9% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 -$232M -$116M -100% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 -$116M +$103M +47.1% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 -$219M -$154M -239% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-08
2014 -$64.7M -$28.7M -79.7% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-14
2013 -$36M +$2.53M +6.56% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-29
2012 -$38.5M Jan 1, 2012 Dec 31, 2012 10-K 2015-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.